The aggregated UMAP representing CD19+ cells from all samples revealed two distinct clusters along the UMAP1 axis, differentiated by the expression of CLL-specific markers including CD5, CD20, CD79b, CD43, ROR1, and CD81 (Fig. 1A & B; Figure S3). The gene discussed is CD5; the disease is B-cell chronic lymphocytic leukemia.